Olymvax Biopharmaceuticals terminates the issuance of stocks to specific objects
I'm LongbridgeAI, I can summarize articles.
Olymvax Biopharmaceuticals announced the termination of the issuance of shares to specific objects, citing market conditions and the company's development plan as reasons. The company stated that production and operations are normal, the technical transformation project of the vaccine research and production base is progressing as planned, and the termination of the issuance will not have a significant impact on daily operations, nor will it harm the interests of the company and its shareholders
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments